GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices
ATLANTA, July 23, 2021 – Elekta (EKTA-B.ST) announced today that GenesisCare , a leading global provider of integrated cancer care, has ordered 27 Flexitron[®] brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to continue to invest in the latest world-class technology while providing access to high-quality care to their patients throughout their U.S. centers.
“With Brachytherapy an essential part of the care pathway for many cancer patients, GenesisCare offers this treatment modality across